Sun Pharma Q2 FY26 Profit Beats Estimates as India Sales Surge 11%, U.S. Innovative Drugs Outperform

Sun Pharmaceutical Industries, India’s top drugmaker by revenue, reported a quarterly profit above analysts estimates on Wednesday, helped by strong demand for its drugs in the domestic market.The Mumbai-based firm’s consolidated net profit stood at 31.18 billion rupees ($354.7 m

Read More

  • Related Posts

    Indian Markets Slide As US-Iran Crisis Reignites

    Indian equities have taken a steep hit after the US-Iran crisis flared up again, with President Trump declaring that the ceasefire with Iran was over. As of this writing, the Nifty 50 is trading at 23,882.85, down 515.85 points or 2.11%, while the BSE Sensex has slipped to 25,012 Read More

    PhonePe Appoints Srijon Biswas CTO; Rahul Chari Now CPTO

    PhonePe has appointed Srijon Biswas, a longtime engineering leader at the company, as its new Chief Technology Officer (CTO), the UPI market leader announced in a statement on July 8. Meanwhile, PhonePe, Co-Founder and former CTO Rahul Chari will take on the newly created role of Read More

    Leave a Reply

    Your email address will not be published. Required fields are marked *